OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Electroconvulsive Therapy for Parkinson's Disease: A Systematic Review and Meta‐Analysis
Akihiro Takamiya, Morinobu Seki, Shun Kudo, et al.
Movement Disorders (2020) Vol. 36, Iss. 1, pp. 50-58
Closed Access | Times Cited: 74
Akihiro Takamiya, Morinobu Seki, Shun Kudo, et al.
Movement Disorders (2020) Vol. 36, Iss. 1, pp. 50-58
Closed Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
Electroconvulsive Therapy
Randall Espinoza, Charles H. Kellner
New England Journal of Medicine (2022) Vol. 386, Iss. 7, pp. 667-672
Closed Access | Times Cited: 175
Randall Espinoza, Charles H. Kellner
New England Journal of Medicine (2022) Vol. 386, Iss. 7, pp. 667-672
Closed Access | Times Cited: 175
The neuropsychiatry of Parkinson's disease: advances and challenges
Daniel Weintraub, Dag Aarsland, К. Ray Chaudhuri, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 89-102
Open Access | Times Cited: 163
Daniel Weintraub, Dag Aarsland, К. Ray Chaudhuri, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 89-102
Open Access | Times Cited: 163
Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment
Stéphane Prange, Hélène Klinger, Chloé Laurencin, et al.
Drugs & Aging (2022) Vol. 39, Iss. 6, pp. 417-439
Open Access | Times Cited: 88
Stéphane Prange, Hélène Klinger, Chloé Laurencin, et al.
Drugs & Aging (2022) Vol. 39, Iss. 6, pp. 417-439
Open Access | Times Cited: 88
Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies
Mir Hilal Ahmad, M. Moshahid A. Rizvi, Mansoor Ali, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101840-101840
Closed Access | Times Cited: 62
Mir Hilal Ahmad, M. Moshahid A. Rizvi, Mansoor Ali, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101840-101840
Closed Access | Times Cited: 62
Management of psychiatric and cognitive complications in Parkinson’s disease
Daniel Weintraub, Dag Aarsland, Roberta Biundo, et al.
BMJ (2022), pp. e068718-e068718
Open Access | Times Cited: 50
Daniel Weintraub, Dag Aarsland, Roberta Biundo, et al.
BMJ (2022), pp. e068718-e068718
Open Access | Times Cited: 50
Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?
Dara Gammon, Catherine Cheng, Anna Volkovinskaia, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1030-1030
Open Access | Times Cited: 53
Dara Gammon, Catherine Cheng, Anna Volkovinskaia, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1030-1030
Open Access | Times Cited: 53
Mood Disorders and Anxiety in Parkinson’s Disease: Current Concepts
Hendrik Lintel, Timothy Corpuz, Saif-ur-Rahman Paracha, et al.
Journal of Geriatric Psychiatry and Neurology (2021) Vol. 34, Iss. 4, pp. 280-288
Closed Access | Times Cited: 36
Hendrik Lintel, Timothy Corpuz, Saif-ur-Rahman Paracha, et al.
Journal of Geriatric Psychiatry and Neurology (2021) Vol. 34, Iss. 4, pp. 280-288
Closed Access | Times Cited: 36
Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications
Milagros Rojas, Daniela Ariza, Ángel Ortega, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6918-6918
Open Access | Times Cited: 28
Milagros Rojas, Daniela Ariza, Ángel Ortega, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6918-6918
Open Access | Times Cited: 28
Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
Efthalia Angelopoulou, Evangelia Stanitsa, Claire Chrysanthi Karpodini, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1454-1454
Open Access | Times Cited: 14
Efthalia Angelopoulou, Evangelia Stanitsa, Claire Chrysanthi Karpodini, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1454-1454
Open Access | Times Cited: 14
Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations - guideline “Parkinson’s disease” of the German Society of Neurology
Karsten Witt, Johannes Levin, Thilo van Eimeren, et al.
Journal of Neurology (2024) Vol. 271, Iss. 12, pp. 7402-7421
Open Access | Times Cited: 6
Karsten Witt, Johannes Levin, Thilo van Eimeren, et al.
Journal of Neurology (2024) Vol. 271, Iss. 12, pp. 7402-7421
Open Access | Times Cited: 6
Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease
Erwin E. H. van Wegen, Tim D. van Balkom, Mark A. Hirsch, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s1, pp. S135-S146
Open Access | Times Cited: 5
Erwin E. H. van Wegen, Tim D. van Balkom, Mark A. Hirsch, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s1, pp. S135-S146
Open Access | Times Cited: 5
Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models
Shawn Hayley, F. Vahid-Ansari, Sun Hongyu, et al.
Neurobiology of Disease (2023) Vol. 181, pp. 106115-106115
Open Access | Times Cited: 12
Shawn Hayley, F. Vahid-Ansari, Sun Hongyu, et al.
Neurobiology of Disease (2023) Vol. 181, pp. 106115-106115
Open Access | Times Cited: 12
Parkinson’s disease psychosis management: an evidence based, experience informed, pragmatic approach
Joseph H. Friedman
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 2, pp. 149-156
Closed Access | Times Cited: 4
Joseph H. Friedman
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 2, pp. 149-156
Closed Access | Times Cited: 4
Neuropsychiatric Manifestations in Parkinson Disease
Daniel Weintraub, Julia Gallagher, Matthew Stern
Cambridge University Press eBooks (2025), pp. 155-165
Closed Access
Daniel Weintraub, Julia Gallagher, Matthew Stern
Cambridge University Press eBooks (2025), pp. 155-165
Closed Access
Treatment options for depression in Parkinson’s disease: a mini-review
Alberto Raggi, Alessandro Serretti, Raffaele Ferri
International Clinical Psychopharmacology (2025)
Closed Access
Alberto Raggi, Alessandro Serretti, Raffaele Ferri
International Clinical Psychopharmacology (2025)
Closed Access
Advances in the study of depression and anxiety in Parkinson’s disease: A review
Zhonglong Wang, Hongkai Wei, Yiliang Xin, et al.
Medicine (2025) Vol. 104, Iss. 10, pp. e41674-e41674
Open Access
Zhonglong Wang, Hongkai Wei, Yiliang Xin, et al.
Medicine (2025) Vol. 104, Iss. 10, pp. e41674-e41674
Open Access
Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial
Ellen Bradley, Kimberly Sakai, Gisele Fernandes‐Osterhold, et al.
Neuropsychopharmacology (2025)
Open Access
Ellen Bradley, Kimberly Sakai, Gisele Fernandes‐Osterhold, et al.
Neuropsychopharmacology (2025)
Open Access
Electroconvulsive therapy for dementia with Lewy bodies: A systematic review and Japanese multicenter survey
Hiroshige Fujishiro, Kuniyuki Iwata‐Endo, Ryota Kobayashi, et al.
Asian Journal of Psychiatry (2025), pp. 104510-104510
Open Access
Hiroshige Fujishiro, Kuniyuki Iwata‐Endo, Ryota Kobayashi, et al.
Asian Journal of Psychiatry (2025), pp. 104510-104510
Open Access
Electroconvulsive therapy: recent advances and anesthetic considerations
Tobias Ninke, Philipp Groene
Current Opinion in Anaesthesiology (2023) Vol. 36, Iss. 4, pp. 441-446
Closed Access | Times Cited: 9
Tobias Ninke, Philipp Groene
Current Opinion in Anaesthesiology (2023) Vol. 36, Iss. 4, pp. 441-446
Closed Access | Times Cited: 9
Safety of electroconvulsive therapy (ECT) in pregnancy: a systematic review of case reports and case series
Salvatore Cipolla, Pierluigi Catapano, Martin Messina, et al.
Archives of Women s Mental Health (2023) Vol. 27, Iss. 2, pp. 157-178
Open Access | Times Cited: 9
Salvatore Cipolla, Pierluigi Catapano, Martin Messina, et al.
Archives of Women s Mental Health (2023) Vol. 27, Iss. 2, pp. 157-178
Open Access | Times Cited: 9
Behind the Mask: Parkinson's Disease and Depression
Sneha Balasubramanian, Khawar Tariq Mehmood, Shahad Al-Baldawi, et al.
Cureus (2024)
Open Access | Times Cited: 3
Sneha Balasubramanian, Khawar Tariq Mehmood, Shahad Al-Baldawi, et al.
Cureus (2024)
Open Access | Times Cited: 3
The Role of Electroconvulsive Therapy in the Treatment of Catatonia Associated With Lewy Body Dementia: A Case Report
Javeria Sahib Din, Thomas Boes, Ernesto Navarro Garcia, et al.
Cureus (2024)
Open Access | Times Cited: 2
Javeria Sahib Din, Thomas Boes, Ernesto Navarro Garcia, et al.
Cureus (2024)
Open Access | Times Cited: 2
In vitro modulation of mTOR and mGlur5 influence α-synuclein accumulation
Viktoria Xing, Kyle K. Biggar, Stephen S. G. Ferguson, et al.
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Viktoria Xing, Kyle K. Biggar, Stephen S. G. Ferguson, et al.
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Convulsive therapy for psychiatric disorders
Tyler S. Kaster, Daniel M. Blumberger
Elsevier eBooks (2024), pp. 241-285
Closed Access | Times Cited: 2
Tyler S. Kaster, Daniel M. Blumberger
Elsevier eBooks (2024), pp. 241-285
Closed Access | Times Cited: 2
Evaluating Electroconvulsive Therapy for Dementia With Lewy Bodies, Including the Prodromal Stage: A Retrospective Study on Safety and Efficacy
Fumiyoshi Morikawa, Ryota Kobayashi, Tomonori Murayama, et al.
International Journal of Geriatric Psychiatry (2024) Vol. 39, Iss. 12
Closed Access | Times Cited: 2
Fumiyoshi Morikawa, Ryota Kobayashi, Tomonori Murayama, et al.
International Journal of Geriatric Psychiatry (2024) Vol. 39, Iss. 12
Closed Access | Times Cited: 2
